Bioceltix SA Sustainability Reports

Bioceltix S.A. engages in the research and development of innovative veterinary biopharmaceuticals. The company specializes in developing stem cell-based therapies for animal use, including treatments for dogs and horses.

Sector: Professional & technical services

Country: Poland

Exchange: Warsaw Stock Exchange

LEI: 259400QZD5JYK8SLZU51

FIGI: BBG013DQ9FB5

No reports are currently available in our catalogue.